RESUMEN
Background and Objectives: A relationship between endometrial polypectomy and in vitro fertilization (IVF) pregnancy outcomes has been reported; however, only a few studies have compared polyp removal techniques and pregnancy rates. We investigated whether different polypectomy techniques with endometrial curettage and hysteroscopic polypectomy for endometrial polyps affect subsequent pregnancy outcomes. Materials and Methods: Data from 434 patients who had undergone polypectomy for suspected endometrial polyps using transvaginal ultrasonography before embryo transfer in IVF at four institutions between January 2017 and December 2020 were retrospectively analyzed. Overall, there were 157 and 277 patients in the hysteroscopic (mean age: 35.0 years) and curettage (mean age: 37.3 years) groups, respectively. Single-blastocyst transfer cases were selected from both groups and age-matched to unify background factors. Results: In the single-blastocyst transfer cases, 148 (mean age: 35.0 years) and 196 (mean age: 35.9 years) were in the hysteroscopic and curettage groups, respectively, with the 148 cases matched by age. In these cases, the pregnancy rates for the first embryo transfer were 68.2% (odds ratio (OR): 2.14) and 51.4% (OR: 1.06) in the hysteroscopic and curettage groups, respectively; the resulting OR was 2.03. The pregnancy rates after up to the second transfer were 80.4% (OR: 4.10) and 68.2% (OR: 2.14) in the hysteroscopic and curettage groups, respectively, in which the OR was 1.91. The live birth rates were 66.2% (OR: 1.956) and 53.4% (OR: 1.15) in the hysteroscopic and curettage groups, respectively, in which the odds ratio was 1.71. These results show the effectiveness of hysteroscopic endometrial polypectomy compared to polypectomy with endometrial curettage. No significant difference was found regarding the miscarriage rates between the two groups. Conclusions: Hysteroscopic endometrial polypectomy resulted in a higher pregnancy rate in subsequent embryo transfer than polypectomy with endometrial curettage. Therefore, establishing a facility where polypectomy can be performed hysteroscopically is crucial.
Asunto(s)
Pólipos , Enfermedades Uterinas , Embarazo , Femenino , Humanos , Adulto , Índice de Embarazo , Estudios Retrospectivos , Enfermedades Uterinas/cirugía , Histeroscopía/métodos , Legrado , Pólipos/cirugíaRESUMEN
Purpose: Early rescue intracytoplasmic sperm injection (ICSI) is often performed in cases in which not even a single oocyte has extruded a second polar body 6 h after insemination. We evaluated the usefulness of expanding the indications of early rescue ICSI to cases in which <80% of oocytes have extruded second polar bodies 6 h after insemination. Methods: Early rescue ICSI was performed on oocytes that were denuded 2.5 h post-insemination and whose extrusion of the second polar bodies had been examined 6 h post-insemination with a PolScope. Results: In vitro fertilization was performed on 24 496 oocytes of 4944 cycles, and 1438 cycles had <80% rate of the second polar body extrusion. Rescue ICSI was performed on 3933 oocytes. Three pronuclei (3PN) incidence of rescue ICSI was 3.0% in oocytes with ≥50% rate of the second polar body extrusion. With respect to the second polar body extrusion rate, no differences were observed in normal fertilization, blastocyst development, implantation, miscarriage, or live birth rates for rescue ICSI. Conclusion: By expanding the indications of early rescue ICSI using the PolScope to cases in which <80% of oocytes have extruded the second polar bodies, many fertilized oocytes can be obtained without considerably increasing the 3PN rate.
RESUMEN
PURPOSE: When rescue artificial oocyte activation (ROA) is performed on the day after intracytoplasmic sperm injection (ICSI) or later, embryonic development is poor and seldom results in live births. The efficacy of an early ROA after ICSI is unclear. Is early ROA effective in rescuing unfertilized oocytes that have not undergone second polar body extrusion several hours after ICSI? METHODS: We performed retrospective cohort study between October 2016 and September 2019, targeting 2891 oocytes in 843 cycles when ICSI was performed. We performed ROA with calcium ionophore on 395 of the 475 oocytes with no second polar extrusion 2.5-6 h after ICSI. RESULTS: The normal fertilization rate of ROA oocytes was significantly higher than non-ROA oocytes (65.8% vs 6.7%, P < 0.001). The blastocyst development rate in ROA oocytes was significantly lower than spontaneously activated oocytes (48.9% vs 67.2%, P < 0.001). The ROA oocyte implantation rate did not significantly differ from the spontaneously activated oocytes (36.0% vs 41.2%). We observed no differences in the implantation rates and blastocyst development rates over the 2.5-6 h from ICSI until ROA. CONCLUSION: Early ROA is effective, and the optimal timing appears to be 2.5-6 h after ICSI.
Asunto(s)
Desarrollo Embrionario/genética , Fertilización In Vitro , Nacimiento Vivo/epidemiología , Oocitos/crecimiento & desarrollo , Blastocisto/efectos de los fármacos , Ionóforos de Calcio/farmacología , Implantación del Embrión/genética , Transferencia de Embrión/tendencias , Desarrollo Embrionario/efectos de los fármacos , Femenino , Humanos , Masculino , Oocitos/efectos de los fármacos , Cuerpos Polares/efectos de los fármacos , Cuerpos Polares/metabolismo , Inyecciones de Esperma Intracitoplasmáticas/tendenciasRESUMEN
Decidualisation of endometrial stromal cells (ESC) is a prerequisite for the implantation of human embryos. Identification of genes that are upregulated or downregulated during decidualisation could lead to a better understanding of the molecular mechanisms involved in this process. In the present study, we examined differences in gene expression between decidualised and non-decidualised cells using microarray analysis and found that Factor XII (FXII) gene expression was upregulated during decidualisation. Furthermore, we also examined the expression of FXII by human ESC before and during pregnancy, as well as its expression by cells that had undergone decidualisation in vitro. Weak expression of FXII mRNA was detected in the non-pregnant endometrium that increased gradually from the proliferative to the secretory endometrium. During pregnancy, FXII mRNA expression was markedly increased in decidualised endometrium. When sex steroids (200 pg mL(-1) of 17beta-oestradiol and 100 ng mL(-1) of progesterone) were used to induce in vitro decidualisation of ESC, the expression of FXII mRNA increased by approximately 25.3-fold compared with that in non-decidualised ESC. Using western blotting, we confirmed the presence of FXII protein (80 kDa) in ESC after in vitro decidualisation. Increased expression of FXII in ESC during decidualisation suggests that the kallikrein-kininogen-kinin system may be activated during the implantation of human embryos.
Asunto(s)
Decidua/metabolismo , Implantación del Embrión/genética , Endometrio/metabolismo , Factor XII/genética , Células del Estroma/metabolismo , Adulto , Western Blotting , Células Cultivadas , Vellosidades Coriónicas/metabolismo , Técnicas de Cocultivo , Decidua/citología , Endometrio/citología , Estradiol/metabolismo , Factor XII/metabolismo , Femenino , Perfilación de la Expresión Génica/métodos , Regulación del Desarrollo de la Expresión Génica , Humanos , Inmunohistoquímica , Ciclo Menstrual/genética , Análisis de Secuencia por Matrices de Oligonucleótidos , Embarazo , Primer Trimestre del Embarazo , Progesterona/metabolismo , ARN Mensajero/metabolismo , Factores de Tiempo , Regulación hacia ArribaRESUMEN
Successful implantation involves a complex interaction between the endometrium and the embryo. It is well known that several neuropeptides are expressed in the endometrium and placenta during embryonal implantation, suggesting an important role as chemical mediators of the feto-maternal relationship. Ghrelin has recently been identified as the endogenous ligand for the GH secretagogue receptor. Ghrelin is a peptide hormone with many physiological functions, and its expression in the human placenta has been reported. To investigate the involvement of ghrelin in embryonal implantation, we assessed the spatio-temporal expression pattern of ghrelin and its receptor in the human endometrium and placenta through the normal menstrual cycle and in early pregnancy. We also examined the effect of ghrelin on the decidualization of endometrial stromal cells (ESC). Weak expression of ghrelin mRNA was detected in the nonpregnant endometrium, and it was dramatically increased in the decidualized endometrium. A GH secretagogue receptor mRNA was detected in the endometrium throughout the normal menstrual cycle and in early pregnancy, but not in the first trimester placenta. Immunohistochemical analysis using an antighrelin antibody revealed strong signals in decidual cells and extravillous trophoblast cells. Coculture with first trimester placenta up-regulated ghrelin mRNA expression by primary cultured ESC, although sex steroids and 8-bromo-cAMP had no effect. In addition, ghrelin enhanced the decidualization of ESC induced by 8-bromo-cAMP (8-Br-cAMP) in vitro. Thus, ghrelin is a novel paracrine/autocrine factor that is involved in cross-talk between the endometrium and embryo during embryonal implantation.
Asunto(s)
Decidua/fisiología , Endometrio/citología , Hormonas Peptídicas/fisiología , Receptores Acoplados a Proteínas G , Células del Estroma/fisiología , 8-Bromo Monofosfato de Adenosina Cíclica/farmacología , Adulto , Células Cultivadas , Técnicas de Cocultivo , Decidua/química , Decidua/citología , Implantación del Embrión/fisiología , Endometrio/química , Femenino , Expresión Génica , Regulación de la Expresión Génica , Edad Gestacional , Ghrelina , Humanos , Inmunohistoquímica , Ciclo Menstrual , Hormonas Peptídicas/genética , Hormonas Peptídicas/farmacología , Placenta/química , Placenta/metabolismo , Embarazo , ARN Mensajero/análisis , Receptores de Superficie Celular/genética , Receptores de Ghrelina , Células del Estroma/efectos de los fármacosRESUMEN
Oligopeptide hormones are involved in cell-cell interaction during embryonal implantation and neuropeptide Y (NPY) is expressed in the human placenta and decidual cells in the third trimester of pregnancy. However, there is no report regarding the intrauterine localisation and the functions of NPY during the peri-implantation period. In the present study, the spatiotemporal changes in NPY expression in the murine uterus during the peri-implantation period were investigated using reverse transcription-polymerase chain reaction (RT-PCR), quantitative RT-PCR and immunohistochemical techniques, as were the effects of sex steroids on NPY mRNA expression in primary cultured murine uterine epithelial cells. Neuropeptide Y mRNA was increased in the pregnant murine uterus, as well as in the pseudopregnant murine uterus, during the peri-implantation period. Immunohistochemical analysis revealed increases in NPY expression in luminal and glandular epithelial cells and decidualised stromal cells. Neuropeptide Y mRNA expression was strongly induced in cultured epithelial cells in response to sex steroids. The data suggest that NPY is involved in cell-cell interactions during embryonic implantation.
Asunto(s)
Comunicación Celular , Implantación del Embrión , Endometrio/metabolismo , Neuropéptido Y/metabolismo , Animales , Comunicación Celular/efectos de los fármacos , Comunicación Celular/genética , Endometrio/química , Endometrio/efectos de los fármacos , Células Epiteliales/química , Células Epiteliales/efectos de los fármacos , Células Epiteliales/metabolismo , Epitelio/química , Epitelio/efectos de los fármacos , Epitelio/metabolismo , Estradiol/farmacología , Femenino , Expresión Génica , Inmunohistoquímica , Ratones , Neuropéptido Y/análisis , Neuropéptido Y/genética , Embarazo , Progesterona/farmacología , ARN Mensajero/análisis , ARN Mensajero/metabolismoRESUMEN
A spinal intradural hemorrhage due to a neurinoma is very rare and requires emergency surgery. We report the first case of a spinal intradural hemorrhage due to a neurinoma in an early puerperal woman. The patient had a history of intermittent episodes of lower back pain for 3 years. The antenatal course to that time had been uneventful. Two days after a normal vaginal delivery, she presented with sudden onset of spinal lesion with severe symptoms and an emergency laminectomy was performed to remove an intradural hemorrhagic lesion due to a neurinoma. In this case, we speculate that clots in the intratumoral vessels spontaneously occurred during pregnancy and obstructions of these vessels followed by necrosis and hemorrhage of distal tissues occurred in the early postpartum stage. Moreover, the change in posture caused by the change in the maternal center of gravity following delivery, as well as the frequent bending required for the care of the newborn, may have been contributing factors. Mild but repetitive traction force caused by the change in posture and frequent bending may have created exertion on the vascular attachment to the nerve roots, causing the intradural hemorrhage.
Asunto(s)
Hemorragia/etiología , Neurilemoma/complicaciones , Complicaciones Neoplásicas del Embarazo/patología , Trastornos Puerperales/etiología , Enfermedades de la Médula Espinal/etiología , Neoplasias de la Médula Espinal/complicaciones , Adulto , Femenino , Humanos , Neurilemoma/cirugía , Postura , Embarazo , Complicaciones Neoplásicas del Embarazo/cirugía , Trastornos Puerperales/patología , Neoplasias de la Médula Espinal/cirugíaRESUMEN
We report a primigravida woman with acute myocardial infarction caused by coronary artery spasm induced by intravenous administration of methyl ergometrine maleate just after delivery. Despite the frequent usage of ergot derivatives to promote uterine contractions, cardiac complications related to this drug are rare. Myocardial infarction may be overlooked in young women in the early postpartum period. Careful monitoring and prompt evaluation should be performed when this drug is administered for obstetrical purposes.
Asunto(s)
Vasoespasmo Coronario/inducido químicamente , Ergonovina/efectos adversos , Infarto del Miocardio/inducido químicamente , Oxitócicos/efectos adversos , Trastornos Puerperales/inducido químicamente , Adulto , Angina Pectoris Variable/etiología , Femenino , Humanos , Periodo Posparto , EmbarazoRESUMEN
Background: Embryo transfer is one of the most critical steps affecting the success of in vitro fertilization/intracytoplasmic sperm injection-embryo transfer. It has been reported that uterine contraction caused by touching the uterine fundus at the time of embryo transfer decreased the pregnancy rate. It was demonstrated that there is a significant rise in the pregnancy rate by adequate positioning of embryos. Transabdominal ultrasound-guided embryo transfer has been reported to improve the pregnancy rate compared with the clinical touch method. The improvement of the pregnancy rate under ultrasound guidance can be attributed to the accurate positioning of the embryos aided by good visualization without touching the uterine fundus. However, sometimes difficulties are encountered when visualizing the tip of the catheter in cases where the patient has a retroflexed uterus. Methods: In the present study, we investigated the difference in the pregnancy rates and in the implantation rates between transabdominal ultrasound-guided group and trans-rectal ultrasound-guided group in retroflexed cases. Results and Conclusion: We found that the pregnancy rate and the implantation rate were higher among the trans-rectal group compared with the transabdominal group in retroflexed cases. The difference between the two groups was statistically significant. (Reprod Med Biol 2003; 2: 159-163).
RESUMEN
PURPOSE: To elucidate the promoter region of human decidual prolactin (dPRL) gene in the human endometrial stromal cells (ESC). METHODS: Various segments of the human dPRL promoter that direct the expression of the secreted alkaline phosphatase (SEAP) reporter gene were transfected into human ESC decidualized by estrogen (E) + progesterone (P) or cyclic AMP (cAMP) to identify E + P or cAMP responsive elements. RESULTS: The region between nucleotides -2038 and -1605 relative to the transcriptional initiation site includes two activator protein-1 (AP-1) sites, which both provided maximal response to E + P or cAMP in decidualized cells. When either AP-1 site was mutated, response in the promoter activity to both E + P or cAMP response showed a decrease compared with control. The region between -310 and -285 that contains consensus-binding sequences for transcription factors of CCAAT/Enhancer-binding proteins (C/EBP) contributed to E + P and cAMP response in decidualized cells. Also, the 5'-flanking region that extends 79 base pairs upstream, including an imperfect cAMP response element (CRE), contributed to E + P and cAMP response. In cells treated with E + P or cAMP for 10 days, mutant of C/EBP-binding site showed an increase in promoter activity comparing to dPRL-2038. In contrast, treatment with PKI showed a decrease in promoter activity in cells treated with E + P or cAMP alone. CONCLUSIONS: These results suggest that cAMP-induced region of the human dPRL promoter resides between -1862 and -1856, -1703 and -1697, -310 and -285, and that the sequences between -1862 and -1856, -1703 and -1697 of the promoter display E + P-induced promoter activity. Furthermore, the current study indicates that E + P or cAMP cooperatively regulate the dPRL gene transcription through some transcriptional factors such as C/EBP, CREB, and other cofactor(s), and that some repressor(s) or corepressor(s) may be involved in the C/EBP-binding site of the human dPRL promoter.
Asunto(s)
AMP Cíclico/farmacología , Decidua/citología , Decidua/metabolismo , Progesterona/farmacología , Prolactina/genética , Regiones Promotoras Genéticas/genética , Células del Estroma/efectos de los fármacos , Región de Flanqueo 5'/genética , Secuencia de Bases , Células Cultivadas , Proteínas Quinasas Dependientes de AMP Cíclico/antagonistas & inhibidores , Estrógenos/farmacología , Femenino , Humanos , Datos de Secuencia Molecular , Inhibidores de Proteínas Quinasas/farmacología , Eliminación de Secuencia , Células del Estroma/metabolismoRESUMEN
A 76-year-old woman with stage IIb cervical cancer with a bulky tumor experienced aortitis during continuous intraarterial cisplatin-based chemotherapy. The chemotherapy was administered through a catheter tip placed in the aorta abdominalis, utilizing an external infusion pump. During the third course of chemotherapy, she complained of left-sided lower back pain and moderate fever was observed. Elevated white blood cell count (WBC) and C-reactive protein (CRP) level were noted, and an abdominal X-ray and urgent computed tomography (CT) were performed. The catheter tip was displaced against the arterial blood flow. At this level of the aortic wall, soft tissue density surrounded the aorta completely. Aortitis caused by the intraarterial chemotherapy, was strongly suspected. It was thought that the maldistribution of drugs and changes in the drug flow occurred due to the vertebral height movement of the catheter tip against the aortic blood flow, and there, flow to the vasa vasorum may have occurred. Chemical vasculitis of the vasa vasorum due to the anticancer drugs was strongly suspected as a contributing factor of the aortitis. Because of the long-term use of an intraarterial catheter, the maldistribution of drugs and changes in the drug flow occurred physically and biologically during the course of the chemotherapy. We recommend occasional monitoring of the location of the catheter tip and a repeat evaluation with contrast medium in regard to flow to the vasa vasorum.